Aarti Pharmalabs Limited
Mumbai, India aartipharmalabs.com From their website, Nov 2026
Work here? Claim this listing
About
Aarti Pharmalabs Limited develops and manufactures APIs, NCEs, HPAPIs, peptides, oligos, payload-linker conjugates, intermediates, and related starting materials for clinical development and commercial production. It serves pharmaceutical and biotechnology customers from sites in Maharashtra and Gujarat, India, with R&D and manufacturing facilities in Nerul, Dombivli, Vapi, Tarapur, and Atali. The company also supplies products for pharmaceutical, nutraceutical, and food/beverages markets and exports to regulated markets worldwide.
Services
Small molecules CDMO
End-to-end contract development and manufacturing services for critical small-molecule drug substances from lab work and pilot scale through clinical trials, launch, and commercial manufacturing.
Peptides & oligos (TIDES)
Development and manufacturing support for peptides and oligonucleotides.
Payload-linker conjugates
Development of payload-linker conjugates, including dedicated OEB-6 laboratory expansion mentioned for this work.
HPAPI development and manufacturing
Development and handling of high-potency APIs with containment-supported R&D and manufacturing capabilities.
Flow chemistry
Continuous-process development and scale-up from laboratory proof-of-concept through commercial manufacturing.
API manufacturing
Manufacture of active pharmaceutical ingredients including generic APIs and anti-cancer APIs.
Intermediates manufacturing
Manufacture of API intermediates, advanced intermediates, key starting materials, regulatory starting materials, and key building blocks.
Caffeine and xanthine derivatives
Production of caffeine and xanthine derivatives for pharmaceutical and food/beverages applications.
8 more services
- Acid & allied products
- Process R&D and scale-up
- HPAPIs
- Route Scouting
- Process R&D
- Technology Transfer
- Validation
- Commercial Manufacturing
Capabilities
As they state on their website or in their listing.
- Processes
- Small molecule
- Peptide
- Oligonucleotide
- Stability studies
- Capacity
- 450 KL/M³ manufacturing capacity at Atali
- Approximately 31,200 litres reactor capacity at Dombivli
- 100 MT per month caffeine capacity at Unit 5
- 5,000 TPA xanthine capacity
- 7 manufacturing units
- 3 R&D centers
- 100 MT per month caffeine production capacity at Unit 5
- Scales
- Ton
Equipment
- Corning G5 Reactor
- CorFlo Reactor
- Corning G1 Reactor
- Fixed Bed Reactor
- MakSpeed Intenseflo Reactor
- Plantrix® MR260
8 more
- Agitated Thin Film Dryer
- Agitated Thin Film Evaporator
- Continuous Crystallizer
- Falling Film Evaporator (FFE)
- Spray Dryer
- Flow reactors
- Autoclaves
- Fume hoods
Industries served
- Pharmaceuticals
- Nutraceuticals
- Food and beverages
- Biotechnology
Company
- Type
- CDMO
- Founded
- 2022
- Team
- 2400+ employees
- Quality
- ISO/IEC 27001:2022 · USFDA (Dombivli Unit; Tarapur Unit 4 mentioned as having inspection/approval) · EUGMP (Tarapur Unit 4 mentioned for audits/approval) · EDQM (Oncology block at Unit 4) · ANVISA (Tarapur Unit 4 audit completion mentioned) · EcoVadis Silver rating · SBTi approved emission reduction targets · Cofepris (Unit 4)
Locations
- Based in
- Mumbai, India
- Sites
- Navi Mumbai, India
- Dombivli, India
- Tarapur, India
- Vapi, India
- Atali, India
- Serves
- USA, European Union, Japan, regulated markets across the globe, global
Contacts
- General enquiry
- info@aartipharmalabs.com on their site
- Phone
- +91 22 6943 6100
Public records
- FDA drug establishment registration
- 3005256484 · API MANUFACTURE source